Out-of-pocket payments are a very big issue, because, of course, either you can pay for your individual treatment or you can't. It's difficult to say how much that would be because it varies so much from one country to another.
I don't know what Ms. Maturu's personal experience has been with accessing treatment that she can speak of, but globally one of the things I want to share with the committee is that we have a very effective pool procurement mechanism set up at the Global Fund that has allowed us to drive down the prices for those critical drugs quite dramatically. If I take the example of antiretroviral therapy, back then, the cost of one year of treatment would have been around $10,000 U.S. a year per person, and it is now down to as low as $72 U.S. a year per person, so imagine.
It's a dramatic decrease that has been enabled by these globally pooled procurement mechanisms that we drive and that have been supported, by the way, by Canada. We have an online platform call wambo that benefits from your support to facilitate those pooled procurements.